ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabrijelcic, J.
Right arrow Articles by Rodríguez-Roisin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabrijelcic, J.
Right arrow Articles by Rodríguez-Roisin, R.
Eur Respir J 2003; 22:290-297
Copyright ©ERS Journals Ltd 2003


Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression

J. Gabrijelcic1, A. Acuña1, M. Profita2, A. Paternò2, K.F. Chung3, A.M. Vignola2 and R. Rodríguez-Roisin1

1 Servei de Pneumologia i Al.lèrgia Respiratòria (ICPCT), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. 2 Istituto di Fisiopatologia Respiratoria, CNR, Palermo, Italy. 3 Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College, London, UK

CORRESPONDENCE: R. Rodríguez-Roisin, Servei de Pneumologia i Al.lèrgia Respiratòria, Hospital Clínic, Villarroel, 170, 08036-Barcelona, Spain. Fax: 34 932275404. E-mail: roisin@medicina.ub.es

Keywords: inflammatory mediators, neutrophil kinetics, obstructive airway diseases

Received: October 25, 2002
Accepted March 4, 2003

This study was supported by the Comissionat per a Universitats i Recerca de la Generalitat de Catalunya (2001-SGR00386), a Research Grant (2000) from the European Respiratory Society (ERS), Ministerio de Sanidady Consumo (Redes Temátions de Investigación Cooperativa, CO3/11) and a grant-in-aid from Esteve Group. A. Acuña was supported byFundación Gran Mariscal de Ayacucho, Caracas, Venezuela, and Instituto de Cooperación Iberoamericana (ICI), Spain.

Platelet-activating factor (PAF)-induced neutrophil lung sequestration may require cell surface adhesion molecules (macrophage-1 antigen (MAC-1) and lymphocyte function-associated antigen-1 (LFA-1)). In this randomised, double-blinded, crossover study, theneutrophil kinetics after PAF and Lyso-PAF (L-PAF) airway challenge were investigated in nine mild-intermittent asthmatics.

Neutrophils were measured in peripheral blood (PB) before and at 5, 15, 45 and 240 min after bronchoprovocation, and in induced sputum before and at 240 min after challenge. MAC-1 and LFA-1 expression were assessed by immunocytochemistry, and leukotriene B4 (LTB4) was measured by enzyme-immunoassay in induced-sputum supernatants.

Compared with baseline, neutrophils in PB decreased 5 min after PAF, while at 240 min neutrophils in induced sputum increased. Compared with baseline and L-PAF, PAF decreased the percentages of MAC-1- and LFA-1-positive neutrophils in PB at 5 min, but increased the percentages of MAC-1 and LFA-1 in neutrophil-induced sputum. Moreover, compared with baseline and L-PAF, PAF-induced sputum revealed higher LTB4 levels, a finding that correlated with the elevated number of neutrophils in induced sputum.

These findings suggest that macrophage-1 antigen and lymphocyte function-associated antigen-1 are involved in platelet-activating factor-induced neutrophil lung traffic, and that this process is modulated by enhanced leukotriene B4 release within the airways.




This article has been cited by other articles:


Home page
Eur Respir JHome page
H. A. Manrique, F. P. Gomez, P. A. Munoz, A. M. Pena, J. A. Barbera, J. Roca, and R. Rodriguez-Roisin
Adenosine 5'-monophosphate in asthma: gas exchange and sputum cellular responses
Eur. Respir. J., June 1, 2008; 31(6): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Gabrijelcic, A. Casas, R.A. Rabinovich, J. Roca, J.A. Barbera, K.F. Chung, and R. Rodriguez-Roisin
Formoterol protects against platelet-activating factor-induced effects in asthma
Eur. Respir. J., January 1, 2004; 23(1): 71 - 75.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.